APA (7th ed.) Citation

SW, S., I, J., AT, T., TT, T., J, S., SA, P., . . . GL, G. (2022). Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy. Arthritis & rheumatology (Hoboken, N.J.), 74(8), 1321. https://doi.org/10.1002/art.42153

Chicago Style (17th ed.) Citation

SW, Syversen, et al. "Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy." Arthritis & Rheumatology (Hoboken, N.J.) 74, no. 8 (2022): 1321. https://doi.org/10.1002/art.42153.

MLA (9th ed.) Citation

SW, Syversen, et al. "Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy." Arthritis & Rheumatology (Hoboken, N.J.), vol. 74, no. 8, 2022, p. 1321, https://doi.org/10.1002/art.42153.